-
公开(公告)号：US20200030420A1
公开(公告)日：2020-01-30
申请号：US16502352
申请日：2019-07-03
Applicant: BIOVERATIV THERAPEUTICS INC.
Inventor： Haiyan JIANG , Lei DIAO , Shuanglian LI , Paula COBB
Abstract: The present invention provides methods of administering a clotting factor by a fixed dosing regimen; methods of reducing, ameliorating, or preventing one or more symptoms of a bleeding disease or disorder; and a kit comprising a dotting factor useful for a fixed dosing regimen. While plasma-derived and recombinant clotting factor products allow hemophilia patients to live longer and healthier, hemophilia still remains one of the most costly and complex conditions to manage.
Search Results
1
records
(took 0.016 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
